bioRxivBiochemistry
Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation
J. A. Macpherson, A. Theisen, L. Masino, L. Fets, P. C. Driscoll, V. Encheva, A. P. Snijders, S. R. Martin, J. Kleinjung, P. E. Barran, F. Fraternali, D. Anastasiou
Abstract
Allosteric regulation is central to the role of the glycolytic enzyme pyruvate kinase M2 (PKM2) in cellular metabolism. Multiple activating and inhibitory allosteric ligands regulate PKM2 activity by controlling the equilibrium between high activity tetramers and low activity dimers and monomers. However, it remains elusive how allosteric inputs upon simultaneous binding of different ligands are integrated to regulate PKM2 activity. Here, we show that, in the presence of the allosteric inhibitor L-phenylalanine (Phe), the activator fructose 1,6-bisphosphate (FBP) can induce PKM2 tetramerisation, but fails to maximally increase enzymatic activity. Guided by a new computational framework we developed to identify residues that mediate FBP-induced allostery, we generated two PKM2 mutants, A327S and C358A, in which activation by FBP remains intact but cannot be attenuated by Phe. Our findings demonstrate a role for residues involved in FBP-induced allostery in enabling the integration of allosteric input from Phe and reveal a mechanism that underlies the co-ordinate regulation of PKM2 activity by multiple allosteric ligands.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bidirectional allosteric ligand regulation in a central glycolytic enzyme
Belen Sundberg, Chenlin Lu, … Anum Azam Glasgow·Journal of the American Chemical SocietyPeer-reviewed·Aug 18, 2026
- The cancer-promoting enzyme PKM2 binds RNA via a positively charged regulatory patch
Pia Sommerkamp, Christian Schillinger, … Matthias W. Hentze·bioRxiv·Sep 23, 2026
- Structural basis for allosteric regulation of human phosphofructokinase-1
E. M. Lynch, H. Hansen, … B. A. Webb·bioRxiv·Mar 15, 2024
- Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets
Q. Tang, M. T. Villar, … A. W. Fenton·bioRxiv·May 9, 2019
- High-resolution Molecular Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2)
Q. Delobelle, T. Jaffrelot-Inizan, … J.-P. Piquemal·bioRxiv·Jan 7, 2024
- Pyruvate kinase allostery resist hyperglycemia, obesity and inflammation by inducing TCA vortex and glucose U turn
Xuan Zhang, Xudong Jiang, … Qian Chen·bioRxiv·Aug 9, 2024